{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:49:11Z","timestamp":1793450951105,"version":"4.5.0"},"reference-count":297,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006408","name":"Ministry of National Education and Religious Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006408","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bcp.2019.03.029","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T11:58:54Z","timestamp":1553255934000},"page":"152-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":240,"special_numbering":"C","title":["The many facets of macrophages in rheumatoid arthritis"],"prefix":"10.1016","volume":"165","author":[{"given":"Eleni","family":"Siouti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Andreakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2019.03.029_b0005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.bcp.2019.03.029_b0010","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2019.03.029_b0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrrheum.2014.64","article-title":"Mechanisms, impact and management of pain in rheumatoid arthritis","volume":"10","author":"Walsh","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0020","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1365-2648.1991.tb01803.x","article-title":"Factors which contribute to fatigue associated with rheumatoid arthritis","volume":"16","author":"Crosby","year":"1991","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.bcp.2019.03.029_b0025","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/rheumatology\/kel021","article-title":"Fatigue in rheumatoid arthritis reflects pain, not disease activity","volume":"45","author":"Pollard","year":"2006","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.bcp.2019.03.029_b0030","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2217\/ijr.11.62","article-title":"Depression in patients with rheumatoid arthritis: description, causes and mechanisms","volume":"6","author":"Margaretten","year":"2011","journal-title":"Int. J. Clin. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2011.09.001","article-title":"Extra-articular manifestations of rheumatoid arthritis: An update","volume":"11","author":"Prete","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bcp.2019.03.029_b0040","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/BOR.0b013e32835f693f","article-title":"Extra-articular rheumatoid arthritis","volume":"25","author":"Turesson","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0045","article-title":"Genetics of rheumatoid arthritis: 2018 status","author":"Okada","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b0050","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0055","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/ard.2009.120170","article-title":"Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk","volume":"69","author":"Karlson","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b0060","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1136\/annrheumdis-2011-201225","article-title":"Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients","volume":"71","author":"Viatte","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b0065","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/art.39619","article-title":"Replication of associations of genetic loci outside the HLA region with susceptibility to anti-cyclic citrullinated peptide-negative rheumatoid arthritis","volume":"68","author":"Viatte","year":"2016","journal-title":"Arthritis Rheumatol. Hoboken NJ."},{"key":"10.1016\/j.bcp.2019.03.029_b0070","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/rheumatology\/32.10.903","article-title":"Twin concordance rates for rheumatoid arthritis: results from a nationwide study","volume":"32","author":"Silman","year":"1993","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0075","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/art.39123","article-title":"DNA methylome signature in synoviocytes from patients with early rheumatoid arthritis compared to synoviocytes from patients with longstanding rheumatoid arthritis","volume":"67","author":"Ai","year":"2015","journal-title":"Arthritis Rheumatol. Hoboken NJ."},{"key":"10.1016\/j.bcp.2019.03.029_b0080","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/BOR.0000000000000471","article-title":"Epigenetics of inflammatory arthritis","volume":"30","author":"Hammaker","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0085","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/gene.2011.45","article-title":"DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts","volume":"12","author":"Karouzakis","year":"2011","journal-title":"Genes Immun."},{"key":"10.1016\/j.bcp.2019.03.029_b0090","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/art.39746","article-title":"LBH gene transcription regulation by the interplay of an enhancer risk allele and DNA methylation in rheumatoid arthritis","volume":"68","author":"Hammaker","year":"2016","journal-title":"Arthritis Rheumatol. Hoboken NJ."},{"key":"10.1016\/j.bcp.2019.03.029_b0095","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.23386","article-title":"Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis","volume":"58","author":"Stanczyk","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0100","doi-asserted-by":"crossref","first-page":"23910","DOI":"10.3390\/ijms141223910","article-title":"Rheumatoid arthritis-associated microRNA-155 targets SOCS1 and upregulates TNF-\u03b1 and Int","volume":"14","author":"Li","year":"2013","journal-title":"J. Mol. Sci."},{"key":"10.1016\/j.bcp.2019.03.029_b0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.smim.2011.01.014","article-title":"Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis","volume":"23","author":"Klareskog","year":"2011","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0110","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/ard.2007.075192","article-title":"Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells","volume":"67","author":"Makrygiannakis","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b0115","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrrheum.2014.115","article-title":"Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis","volume":"10","author":"Catrina","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0120","doi-asserted-by":"crossref","first-page":"30594","DOI":"10.1038\/srep30594","article-title":"Role of the gut microbiome in modulating arthritis progression in mice","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2019.03.029_b0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13075-016-0927-z","article-title":"Tapering and discontinuation of TNF-\u03b1 blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission","volume":"18","author":"Alivernini","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcp.2019.03.029_b0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2019.03.029_b0135","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/BOR.0b013e32835fd8eb","article-title":"New learnings on the pathophysiology of RA from synovial biopsies","volume":"25","author":"Pitzalis","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0140","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/ar4555","article-title":"Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics","volume":"16","author":"Dennis","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcp.2019.03.029_b0145","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrrheum.2016.91","article-title":"Macrophage heterogeneity in the context of rheumatoid arthritis","volume":"12","author":"Udalova","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0150","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/ar2333","article-title":"Cells of the synovium in rheumatoid arthritis. Macrophages","volume":"9","author":"Kinne","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcp.2019.03.029_b0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/art.1780390116","article-title":"Synovial tissue macrophage populations and articular damage in rheumatoid arthritis","volume":"39","author":"Mulherin","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.berh.2008.02.002","article-title":"Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials","volume":"22","author":"Gerlag","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0165","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/rheumatology\/38.9.818","article-title":"Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis","volume":"38","author":"Richards","year":"1999","journal-title":"Rheumatology Oxf. Engl."},{"issue":"Suppl.","key":"10.1016\/j.bcp.2019.03.029_b0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0896-8411(89)90129-7","article-title":"Cytokine production in culture by cells isolated from the synovial membrane","volume":"2","author":"Brennan","year":"1989","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bcp.2019.03.029_b0175","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.1780351008","article-title":"Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases","volume":"35","author":"Cope","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0090-1229(92)90106-X","article-title":"In situ hybridization of interleukin-1 in CD14-positive cells in rheumatoid arthritis","volume":"62","author":"Wood","year":"1992","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.bcp.2019.03.029_b0185","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1084\/jem.179.5.1517","article-title":"Immunoregulatory role of interleukin 10 in rheumatoid arthritis","volume":"179","author":"Katsikis","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b0190","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/clin.1995.1114","article-title":"Increased synovial expression of transforming growth factor (TGF)-beta receptor endoglin and TGF-beta 1 in rheumatoid arthritis: possible interactions in the pathogenesis of the disease","volume":"76","author":"Szekanecz","year":"1995","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.bcp.2019.03.029_b0195","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","article-title":"Role of cytokines in rheumatoid arthritis","volume":"14","author":"Feldmann","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm0296-175","article-title":"The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis","volume":"2","author":"McInnes","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b0205","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI7317","article-title":"A proinflammatory role for IL-18 in rheumatoid arthritis","volume":"104","author":"Gracie","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2019.03.029_b0210","first-page":"449","article-title":"Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha","volume":"73","author":"Buchan","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0215","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0896-8411(88)90006-6","article-title":"Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis","volume":"1","author":"Husby","year":"1988","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bcp.2019.03.029_b0220","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/art.1780310816","article-title":"Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum","volume":"31","author":"Saxne","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0225","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(89)90430-3","article-title":"Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis","volume":"2","author":"Brennan","year":"1989","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.bcp.2019.03.029_b0230","first-page":"225","article-title":"Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist","volume":"6","author":"Butler","year":"1995","journal-title":"Eur. Cytokine Network"},{"issue":"154","key":"10.1016\/j.bcp.2019.03.029_b0235","first-page":"1432","article-title":"Balance of IL-1 receptor antagonist\/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10","volume":"1950","author":"Chomarat","year":"1995","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.bcp.2019.03.029_b0240","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/322547a0","article-title":"Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage","volume":"322","author":"Saklatvala","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2019.03.029_b0245","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","article-title":"Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis","volume":"10","author":"Keffer","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2019.03.029_b0250","doi-asserted-by":"crossref","first-page":"9784","DOI":"10.1073\/pnas.89.20.9784","article-title":"Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis","volume":"89","author":"Williams","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.03.029_b0255","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/ard.58.7.428","article-title":"Anti-inflammatory effects of systemic anti-tumour necrosis factor alpha treatment in human\/murine SCID arthritis","volume":"58","author":"Sch\u00e4dlich","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b0260","first-page":"86","article-title":"Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice","volume":"46","author":"Georgopoulos","year":"1996","journal-title":"J. Inflamm."},{"key":"10.1016\/j.bcp.2019.03.029_b0265","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.163.6.1433","article-title":"Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1","volume":"163","author":"Dinarello","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b0270","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/eji.1830181122","article-title":"Excessive production of interleukin 6\/B cell stimulatory factor-2 in rheumatoid arthritis","volume":"18","author":"Hirano","year":"1988","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0275","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/art.1780310614","article-title":"Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides","volume":"31","author":"Houssiau","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0280","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1172\/JCI113921","article-title":"Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis","volume":"83","author":"Guerne","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2019.03.029_b0285","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","article-title":"Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6","volume":"90","author":"Tamura","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.03.029_b0290","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jbmr.5650110113","article-title":"Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation","volume":"11","author":"Kotake","year":"1996","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2019.03.029_b0295","first-page":"177","article-title":"Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice","volume":"151","author":"van de Loo","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2019.03.029_b0300","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.187.4.461","article-title":"Interleukin 6 is required for the development of collagen-induced arthritis","volume":"187","author":"Alonzi","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b0305","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.1073\/pnas.95.14.8222","article-title":"Interleukin 6 plays a key role in the development of antigen-induced arthritis","volume":"95","author":"Ohshima","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.03.029_b0310","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1006\/cyto.1999.0502","article-title":"Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis","volume":"11","author":"Boe","year":"1999","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2019.03.029_b0315","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1074-7613(00)80664-0","article-title":"IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation","volume":"9","author":"Lodolce","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2019.03.029_b0320","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00763","article-title":"Unique action of interleukin-18 on T cells and other immune cells","volume":"9","author":"Nakanishi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0325","doi-asserted-by":"crossref","first-page":"ii100","DOI":"10.1136\/ard.61.suppl_2.ii100","article-title":"Role of interleukin 15 and interleukin 18 in inflammatory response","volume":"61","author":"Liew","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b0330","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm0296-175","article-title":"The role of interleukin\u201315 in T\u2013cell migration and activation in rheumatoid arthritis","volume":"2","author":"McInnes","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b0335","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity","volume":"18","author":"Karin","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0340","first-page":"827","article-title":"High DNA-binding activity of transcription factor NF-kappa B in synovial membranes of patients with rheumatoid arthritis","volume":"37","author":"Asahara","year":"1995","journal-title":"Biochem. Mol. Biol. Int."},{"key":"10.1016\/j.bcp.2019.03.029_b0345","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/art.1780390407","article-title":"Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue","volume":"39","author":"Marok","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0350","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1073\/pnas.96.10.5668","article-title":"Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators","volume":"96","author":"Bondeson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.03.029_b0355","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/art.11044","article-title":"Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy","volume":"48","author":"Andreakos","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0360","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1182\/blood-2002-06-1835","article-title":"I\u03baB kinase 2 but not NF-\u03baB\u2013inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction","volume":"101","author":"Andreakos","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2019.03.029_b0365","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1242\/jcs.00286","article-title":"VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2","volume":"116","author":"Kiriakidis","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2019.03.029_b0370","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.0105-2896.2004.00202.x","article-title":"Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?","volume":"202","author":"Andreakos","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bcp.2019.03.029_b0375","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4","article-title":"Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation","volume":"44","author":"Tak","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"Suppl. 2","key":"10.1016\/j.bcp.2019.03.029_b0380","doi-asserted-by":"crossref","first-page":"ii13","DOI":"10.1136\/ard.61.suppl_2.ii13","article-title":"Is NF-kappaB a useful therapeutic target in rheumatoid arthritis?","volume":"61","author":"Feldmann","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"147","key":"10.1016\/j.bcp.2019.03.029_b0385","first-page":"2187","article-title":"Synovial tissue macrophage as a source of the chemotactic cytokine IL-8","volume":"1950","author":"Koch","year":"1991","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.bcp.2019.03.029_b0390","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1172\/JCI115950","article-title":"Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis","volume":"90","author":"Koch","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2019.03.029_b0395","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/1043-4666(94)90038-8","article-title":"Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs","volume":"6","author":"Loetscher","year":"1994","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2019.03.029_b0400","first-page":"245","article-title":"Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints","volume":"10","author":"Endo","year":"1991","journal-title":"Lymphokine Cytokine Res."},{"key":"10.1016\/j.bcp.2019.03.029_b0405","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/ar141","article-title":"The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8)","volume":"3","author":"Kraan","year":"2001","journal-title":"Arthritis Res."},{"key":"10.1016\/j.bcp.2019.03.029_b0410","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.1780360605","article-title":"Expression of monocyte chemotactic and activating factor in rheumatoid arthritis. Regulation of its production in synovial cells by interleukin-1 and tumor necrosis factor","volume":"36","author":"Akahoshi","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0415","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1172\/JCI117414","article-title":"Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis","volume":"94","author":"Koch","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"155","key":"10.1016\/j.bcp.2019.03.029_b0420","first-page":"3660","article-title":"Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis","volume":"1950","author":"Koch","year":"1995","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.bcp.2019.03.029_b0425","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/clim.2000.4957","article-title":"CXCR3 and CCR5 ligands in rheumatoid arthritis synovium","volume":"98","author":"Patel","year":"2001","journal-title":"Clin. Immunol. Orlando Fla."},{"key":"10.1016\/j.bcp.2019.03.029_b0430","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/ard.62.8.715","article-title":"Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis","volume":"62","author":"Haringman","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b0435","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/1529-0131(200105)44:5<1022::AID-ANR181>3.0.CO;2-N","article-title":"Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes\/macrophages in rheumatoid arthritis","volume":"44","author":"Katschke","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0440","first-page":"3818","article-title":"Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence","volume":"10","author":"Zhang","year":"1990","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2019.03.029_b0445","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/34.4.321","article-title":"Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor","volume":"34","author":"Mihara","year":"1995","journal-title":"Br. J. Rheumatol."},{"issue":"167","key":"10.1016\/j.bcp.2019.03.029_b0450","first-page":"5395","article-title":"Cross-talk between IL-1 and IL-6 signaling pathways in rheumatoid arthritis synovial fibroblasts","volume":"1950","author":"Deon","year":"2001","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.bcp.2019.03.029_b0455","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0460","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/345442a0","article-title":"The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene","volume":"345","author":"Yoshida","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2019.03.029_b0465","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/rheumatology\/33.7.613","article-title":"Constitutive mRNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid arthritis and osteoarthritis patients","volume":"33","author":"Seitz","year":"1994","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0470","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/1529-0131(200011)43:11<2523::AID-ANR20>3.0.CO;2-Z","article-title":"Expression of osteoclast differentiation factor in rheumatoid arthritis","volume":"43","author":"Shigeyama","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0475","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","article-title":"Involvement of receptor activator of nuclear factor kappaB ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis","volume":"43","author":"Takayanagi","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0480","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/08977199309010831","article-title":"Regulation of macrophage colony-stimulating factor (M-CSF) production in cultured human synovial fibroblasts","volume":"9","author":"Hamilton","year":"1993","journal-title":"Growth Factors Chur Switz."},{"key":"10.1016\/j.bcp.2019.03.029_b0485","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1053\/berh.2001.0195","article-title":"Metalloproteases and inhibitors in arthritic diseases","volume":"15","author":"Martel-Pelletier","year":"2001","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0490","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bcp.2019.03.029_b0495","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1137306","article-title":"Cadherin-11 in synovial lining formation and pathology in arthritis","volume":"315","author":"Lee","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.bcp.2019.03.029_b0500","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/art.22573","article-title":"Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes","volume":"56","author":"Tran","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0505","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/BF00918651","article-title":"Distribution of CD45RA and CD45RO T-lymphocyte subsets in rheumatoid arthritis synovial tissue","volume":"10","author":"Koch","year":"1990","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0510","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/art.1780351209","article-title":"Rheumatoid synovium is enriched in CD45RBdim mature memory T cells that are potent helpers for B cell differentiation","volume":"35","author":"Thomas","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0515","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/ard.60.6.561","article-title":"Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA","volume":"60","author":"Smeets","year":"2001","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl. 3","key":"10.1016\/j.bcp.2019.03.029_b0520","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1186\/ar558","article-title":"The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction","volume":"4","author":"Burger","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.bcp.2019.03.029_b0525","doi-asserted-by":"crossref","first-page":"R168","DOI":"10.1186\/ar2077","article-title":"T-cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NFkappaB: implications for rheumatoid arthritis","volume":"8","author":"Beech","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcp.2019.03.029_b0530","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/eji.1830270308","article-title":"Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis","volume":"27","author":"Sebbag","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0535","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.aaf8924","article-title":"Pain regulation by non-neuronal cells and inflammation","volume":"354","author":"Ji","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bcp.2019.03.029_b0540","series-title":"Transl. Pain Res. Mouse Man","article-title":"Cytokines in Pain","author":"Shubayev","year":"2010"},{"key":"10.1016\/j.bcp.2019.03.029_b0545","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1523\/JNEUROSCI.17-03-00975.1997","article-title":"Tumor necrosis factor enhances the capsaicin sensitivity of rat sensory neurons","volume":"17","author":"Nicol","year":"1997","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.bcp.2019.03.029_b0550","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1523\/JNEUROSCI.21-14-05027.2001","article-title":"Chemokines and glycoprotein 120 produce pain hypersensitivity by directly exciting primary nociceptive neurons","volume":"21","author":"Oh","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2019.03.029_b0555","first-page":"1497","article-title":"IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C","volume":"16","author":"Obreja","year":"2002","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.bcp.2019.03.029_b0560","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1073\/pnas.0406030102","article-title":"A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.03.029_b0565","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.1073\/pnas.0503496102","article-title":"Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion","volume":"102","author":"White","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.03.029_b0570","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1744-8069-3-27","article-title":"Transformation of the output of spinal lamina I neurons after nerve injury and microglia stimulation underlying neuropathic pain","volume":"3","author":"Keller","year":"2007","journal-title":"Mol. Pain"},{"key":"10.1016\/j.bcp.2019.03.029_b0575","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic pain phenotype to reveal neural mechanisms","volume":"73","author":"von Hehn","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2019.03.029_b0580","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.pain.2014.03.022","article-title":"Primary afferent input critical for maintaining spontaneous pain in peripheral neuropathy","volume":"155","author":"Haroutounian","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2019.03.029_b0585","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/glia.10161","article-title":"Microglia as a source and target of cytokines","volume":"40","author":"Hanisch","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2019.03.029_b0590","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbi.2006.10.011","article-title":"Glia as the \u201cbad guys\u201d: Implications for improving clinical pain control and the clinical utility of opioids","volume":"21","author":"Watkins","year":"2007","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.bcp.2019.03.029_b0595","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1471-4159.2002.01184.x","article-title":"Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells","volume":"83","author":"Pinteaux","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2019.03.029_b0600","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1523\/JNEUROSCI.0176-07.2007","article-title":"Glial\u2013cytokine\u2013neuronal interactions underlying the mechanisms of persistent pain","volume":"27","author":"Guo","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2019.03.029_b0605","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0006-8993(99)01326-8","article-title":"Acute peripheral inflammation induces moderate glial activation and spinal IL-1\u03b2 expression that correlates with pain behavior in the rat1Published on the World Wide Web on 17 March 1999.1","volume":"829","author":"Sweitzer","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2019.03.029_b0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3959(00)00490-5","article-title":"The role of neuroinflammation and neuroimmune activation in persistent pain","volume":"90","author":"DeLeo","year":"2001","journal-title":"PAIN"},{"key":"10.1016\/j.bcp.2019.03.029_b0615","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neulet.2003.12.007","article-title":"Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia","volume":"361","author":"Sommer","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2019.03.029_b0620","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1002\/art.23063","article-title":"Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade","volume":"56","author":"Inglis","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0625","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/art.39082","article-title":"Calcitonin gene-related peptide-expressing sensory neurons and spinal microglial reactivity contribute to pain states in collagen-induced arthritis","volume":"67","author":"Nieto","year":"2015","journal-title":"Arthritis Rheumatol. Hoboken NJ."},{"key":"10.1016\/j.bcp.2019.03.029_b0630","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/art.38682","article-title":"Subgrouping of patients with rheumatoid arthritis based on pain, fatigue, inflammation, and psychosocial factors","volume":"66","author":"Lee","year":"2014","journal-title":"Arthritis Rheumatol. Hoboken NJ."},{"key":"10.1016\/j.bcp.2019.03.029_b0635","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/ar2684","article-title":"Enhanced reactivity to pain in patients with rheumatoid arthritis","volume":"11","author":"Edwards","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcp.2019.03.029_b0640","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3899\/jrheum.110668","article-title":"Pain thresholds in rheumatoid arthritis: the effect of tender point counts and disease duration","volume":"39","author":"Pollard","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0645","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12974-016-0556-0","article-title":"Neuron-immune mechanisms contribute to pain in early stages of arthritis","volume":"13","author":"Nieto","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"Suppl. 107","key":"10.1016\/j.bcp.2019.03.029_b0650","first-page":"94","article-title":"Pain mechanisms in rheumatoid arthritis","volume":"35","author":"McWilliams","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0655","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11914-018-0473-5","article-title":"Mechanisms for Joint Pain in Rheumatoid Arthritis (RA): from Cytokines to Central Sensitization","volume":"16","author":"Zhang","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bcp.2019.03.029_b0660","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0006-8993(00)02807-9","article-title":"Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain","volume":"879","author":"Arruda","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2019.03.029_b0665","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0306-4522(00)00574-1","article-title":"Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain","volume":"103","author":"Sweitzer","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2019.03.029_b0670","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejpain.2008.04.017","article-title":"CCL2 is a key mediator of microglia activation in neuropathic pain states","volume":"13","author":"Thacker","year":"2009","journal-title":"Eur. J. Pain Lond. Engl."},{"key":"10.1016\/j.bcp.2019.03.029_b0675","doi-asserted-by":"crossref","first-page":"12728","DOI":"10.1073\/pnas.1118748109","article-title":"Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice","volume":"109","author":"Lampa","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.03.029_b0680","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jneuroim.2015.02.002","article-title":"Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain \u2014 interleukin-8 in fibromyalgia and interleukin-1 \u03b2 in rheumatoid arthritis","volume":"280","author":"Kosek","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0685","first-page":"845","article-title":"The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells","volume":"46","author":"van Furth","year":"1972","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.bcp.2019.03.029_b0690","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fimmu.2015.00328","article-title":"From the reticuloendothelial to mononuclear phagocyte system \u2013 the unaccounted years","volume":"6","author":"Yona","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0695","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2019.03.029_b0700","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fimmu.2015.00423","article-title":"Blood monocytes and their subsets: established features and open questions","volume":"6","author":"Ziegler-Heitbrock","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0705","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood.V74.7.2527.2527","article-title":"Identification and characterization of a novel monocyte subpopulation in human peripheral blood","volume":"74","author":"Passlick","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2019.03.029_b0710","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/rheumatology\/keg174","article-title":"Fc\u03b3 receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rate who do not use anti-rheumatic drugs","volume":"42","author":"Lafeber","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.bcp.2019.03.029_b0715","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.33418","article-title":"The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population","volume":"64","author":"Rossol","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109775","article-title":"Functional phenotype of synovial monocytes modulating inflammatory T-cell responses in rheumatoid arthritis (RA)","volume":"9","author":"Yoon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2019.03.029_b0725","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.immuni.2010.08.012","article-title":"Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors","volume":"33","author":"Cros","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2019.03.029_b0730","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1182\/blood-2009-07-235028","article-title":"Comparison of gene expression profiles between human and mouse monocyte subsets","volume":"115","author":"Ingersoll","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2019.03.029_b0735","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.it.2011.05.001","article-title":"Monocyte trafficking in acute and chronic inflammation","volume":"32","author":"Ingersoll","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0740","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1172\/JCI116307","article-title":"Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy","volume":"91","author":"Hahn","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2019.03.029_b0745","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/1529-0131(200004)43:4<775::AID-ANR8>3.0.CO;2-7","article-title":"Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis","volume":"43","author":"Stuhlmuller","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"20","key":"10.1016\/j.bcp.2019.03.029_b0750","article-title":"Anti-CD11b antibody treatment suppresses the osteoclast generation, inflammatory cell infiltration, and autoantibody production in arthritis-prone FcgammaRIIB-deficient mice","volume":"25","author":"Ohtsuji","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcp.2019.03.029_b0755","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11926-012-0272-4","article-title":"Managing macrophages in rheumatoid arthritis by reform or removal","volume":"14","author":"Li","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.bcp.2019.03.029_b0760","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0003-4967(24)43164-6","article-title":"CD68 is not a macrophage-specific antigen","volume":"64","author":"Beranek","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b0765","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(81)91107-7","article-title":"Rheumatoid arthritis: a disease of T-lymphocyte\/macrophage immunoregulation","volume":"2","author":"Janossy","year":"1981","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.bcp.2019.03.029_b0770","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/art.10940","article-title":"Selective elimination of synovial inflammatory macrophages in rheumatoid arthritis by an Fcgamma receptor I-directed immunotoxin","volume":"48","author":"van Roon","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"176","key":"10.1016\/j.bcp.2019.03.029_b0775","first-page":"5833","article-title":"CD64-directed immunotoxin inhibits arthritis in a novel CD64 transgenic rat model","volume":"1950","author":"van Vuuren","year":"2006","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.bcp.2019.03.029_b0780","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/art.1780390517","article-title":"Accelerated generation of CD14+ monocyte-lineage cells from the bone marrow of rheumatoid arthritis patients","volume":"39","author":"Hirohata","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0785","first-page":"1511","article-title":"Detection of myeloid precursors (granulocyte\/macrophage colony forming units) in the bone marrow adjacent to rheumatoid arthritis joints","volume":"19","author":"Kotake","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0790","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri746","article-title":"Mouse and human dendritic cell subtypes","volume":"2","author":"Shortman","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0795","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","article-title":"The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting","volume":"31","author":"Merad","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0800","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0805","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.immuni.2012.04.012","article-title":"Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells","volume":"37","author":"Haniffa","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2019.03.029_b0810","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-immunol-031210-101345","article-title":"Plasmacytoid dendritic cells: recent progress and open questions","volume":"29","author":"Reizis","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0815","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1172\/JCI112036","article-title":"Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis","volume":"76","author":"Zvaifler","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2019.03.029_b0820","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/art.21211","article-title":"RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes","volume":"52","author":"Page","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"167","key":"10.1016\/j.bcp.2019.03.029_b0825","first-page":"1758","article-title":"Dendritic cells (DCs) in rheumatoid arthritis (RA): progenitor cells and soluble factors contained in RA synovial fluid yield a subset of myeloid DCs that preferentially activate Th1 inflammatory-type responses","volume":"1950","author":"Santiago-Schwarz","year":"2001","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.bcp.2019.03.029_b0830","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/ard.2004.023259","article-title":"Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritis","volume":"64","author":"van Lieshout","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"169","key":"10.1016\/j.bcp.2019.03.029_b0835","first-page":"7071","article-title":"A novel dendritic cell-induced model of erosive inflammatory arthritis: distinct roles for dendritic cells in T cell activation and induction of local inflammation","volume":"1950","author":"Leung","year":"2002","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.bcp.2019.03.029_b0840","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.immuni.2016.02.024","article-title":"Tissue-resident macrophage ontogeny and homeostasis","volume":"44","author":"Ginhoux","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2019.03.029_b0845","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1126\/science.1251414","article-title":"The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal","volume":"344","author":"Rosas","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bcp.2019.03.029_b0850","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1038\/ncomms2877","article-title":"Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation","volume":"4","author":"Davies","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2019.03.029_b0855","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","article-title":"Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis","volume":"38","author":"Yona","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2019.03.029_b0860","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri3671","article-title":"Monocytes and macrophages: developmental pathways and tissue homeostasis","volume":"14","author":"Ginhoux","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0865","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.immuni.2016.02.017","article-title":"Yolk sac macrophages, fetal liver, and adult monocytes can colonize an empty niche and develop into functional tissue-resident macrophages","volume":"44","author":"van de Laar","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2019.03.029_b0870","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/03009748709102927","article-title":"Macrophage-like cells of the pannus area in rheumatoid Arthritic joints","volume":"16","author":"Salisbury","year":"1987","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b0875","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/rheumatology\/36.9.935","article-title":"Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane","volume":"36","author":"Cauli","year":"1997","journal-title":"Br. J. Rheumatol."},{"issue":"193","key":"10.1016\/j.bcp.2019.03.029_b0880","first-page":"2373","article-title":"Modulation of TNF-induced macrophage polarization by synovial fibroblasts","volume":"1950","author":"Donlin","year":"2014","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.bcp.2019.03.029_b0885","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V79.6.1413.1413","article-title":"Cytokine regulation of colony-stimulating factor (CSF) production in cultured human synovial fibroblasts. II. Similarities and differences in the control of interleukin-1 induction of granulocyte-macrophage CSF and granulocyte-CSF production","volume":"79","author":"Hamilton","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2019.03.029_b0890","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1172\/JCI87828","article-title":"Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation","volume":"126","author":"Achuthan","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2019.03.029_b0895","doi-asserted-by":"crossref","first-page":"ii60","DOI":"10.1136\/ard.62.suppl_2.ii60","article-title":"Angiogenesis as a target in rheumatoid arthritis","volume":"62","author":"Koch","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b0900","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.celrep.2014.09.032","article-title":"Nonclassical Ly6C(-) monocytes drive the development of inflammatory arthritis in mice","volume":"9","author":"Misharin","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2019.03.029_b0905","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1073\/pnas.1506254112","article-title":"IRF5 controls both acute and chronic inflammation","volume":"112","author":"Weiss","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.03.029_b0910","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.176.1.287","article-title":"Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation","volume":"176","author":"Stein","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b0915","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1159\/000364945","article-title":"M1 and M2 macrophages: the chicken and the egg of immunity","volume":"6","author":"Mills","year":"2014","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.bcp.2019.03.029_b0920","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0400983101","article-title":"Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria","volume":"101","author":"Verreck","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.03.029_b0925","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/816460","article-title":"Understanding the mysterious M2 macrophage through activation markers and effector mechanisms","volume":"2015","author":"R\u0151szer","year":"2015","journal-title":"Mediators Inflammation"},{"key":"10.1016\/j.bcp.2019.03.029_b0930","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2019.03.029_b0935","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2011.00052","article-title":"Macrophages in synovial inflammation","volume":"2","author":"Kennedy","year":"2011","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0940","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3389\/fimmu.2017.01958","article-title":"M1 and M2 monocytes in rheumatoid arthritis: a contribution of imbalance of M1\/M2 monocytes to osteoclastogenesis","volume":"8","author":"Fukui","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0945","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/ar294","article-title":"IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis","volume":"3","author":"Chabaud","year":"2001","journal-title":"Arthritis Res."},{"key":"10.1016\/j.bcp.2019.03.029_b0950","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s10753-015-0188-z","article-title":"Anti-citrullinated protein antibodies induce macrophage subset disequilibrium in RA patients","volume":"38","author":"Zhu","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.bcp.2019.03.029_b0955","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/jbmr.3117","article-title":"Targeting notch-activated M1 macrophages attenuates joint tissue damage in a mouse model of inflammatory arthritis","volume":"32","author":"Sun","year":"2017","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2019.03.029_b0960","doi-asserted-by":"crossref","first-page":"e2524","DOI":"10.1038\/cddis.2016.442","article-title":"Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis","volume":"7","author":"Shin","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b0965","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.biomaterials.2015.05.028","article-title":"Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis","volume":"61","author":"Jain","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2019.03.029_b0970","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20151570","article-title":"Immunometabolism governs dendritic cell and macrophage function","volume":"213","author":"O\u2019Neill","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b0975","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.coi.2017.04.010","article-title":"Metabolic signatures of T-cells and macrophages in rheumatoid arthritis","volume":"46","author":"Weyand","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b0980","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/art.1780140407","article-title":"Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases","volume":"14","author":"Treuhaft","year":"1971","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b0985","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-5793(93)80636-9","article-title":"A comparative evaluation of the metabolic profiles of normal and inflammatory knee-joint synovial fluids by high resolution proton NMR spectroscopy","volume":"332","author":"Naughton","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2019.03.029_b0990","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/ard.2009.119776","article-title":"Synovial tissue hypoxia and inflammation in vivo","volume":"69","author":"Ng","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b0995","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/10715769609149921","article-title":"Enhanced mitochondrial radical production in patients which rheumatoid arthritis correlates with elevated levels of tumor necrosis factor alpha in plasma","volume":"25","author":"Miesel","year":"1996","journal-title":"Free Radical Res."},{"key":"10.1016\/j.bcp.2019.03.029_b1000","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.autrev.2016.01.006","article-title":"Coexistence of ischemic heart disease and rheumatoid arthritis patients-a case control study","volume":"15","author":"Houri Levi","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bcp.2019.03.029_b1005","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/annrheumdis-2017-212647","article-title":"Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation","volume":"77","author":"Zeisbrich","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b1010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.20150900","article-title":"The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease","volume":"213","author":"Shirai","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b1015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrrheum.2017.49","article-title":"Immunometabolism in early and late stages of rheumatoid arthritis","volume":"13","author":"Weyand","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b1020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cei.12667","volume":"182","author":"Ruscitti","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b1025","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7","article-title":"Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint","volume":"44","author":"Hollander","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2019.03.029_b1035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","article-title":"HIF-1alpha is essential for myeloid cell-mediated inflammation","volume":"112","author":"Cramer","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2019.03.029_b1040","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1084\/jem.20160061","article-title":"GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis","volume":"213","author":"Littlewood-Evans","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b1045","doi-asserted-by":"crossref","first-page":"R181","DOI":"10.1186\/ar4011","article-title":"Human monocytes and macrophages differ in their mechanisms of adaptation to hypoxia","volume":"14","author":"Fangradt","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcp.2019.03.029_b1050","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1089\/ars.2008.2400","article-title":"Hypoxia activates NF-kappaB-dependent gene expression through the canonical signaling pathway","volume":"11","author":"Oliver","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2019.03.029_b1055","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1091\/mbc.e02-09-0598","article-title":"Tumor necrosis factor-\u03b1 causes accumulation of a ubiquitinated form of hypoxia inducible factor-1\u03b1 through a nuclear factor-\u03baB-dependent pathway","volume":"14","author":"Zhou","year":"2003","journal-title":"Mol. Biol. Cell."},{"key":"10.1016\/j.bcp.2019.03.029_b1060","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00018-011-0876-2","article-title":"NF\u03baB and HIF display synergistic behaviour during hypoxic inflammation","volume":"69","author":"Bruning","year":"2012","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.bcp.2019.03.029_b1065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4161\/jkst.20662","article-title":"PKM2, STAT3 and HIF-1\u03b1","volume":"1","author":"Demaria","year":"2012","journal-title":"JAK-STAT."},{"key":"10.1016\/j.bcp.2019.03.029_b1070","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/annrheumdis-2013-204105","article-title":"Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis","volume":"74","author":"Gao","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b1075","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-018-0210-x","article-title":"Hypoxia-induced the upregulation of stromal cell-derived factor 1 in fibroblast-like synoviocytes contributes to migration of monocytes into synovium tissue in rheumatoid arthritis","volume":"8","author":"Yang","year":"2018","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bcp.2019.03.029_b1080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.immuni.2017.06.018","article-title":"Hypoxia-sensitive COMMD1 integrates signaling and cellular metabolism in human macrophages and suppresses osteoclastogenesis","volume":"47","author":"Murata","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2019.03.029_b1085","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cmet.2012.05.008","article-title":"Polarizing macrophages through reprogramming of glucose metabolism","volume":"15","author":"Blagih","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2019.03.029_b1090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.immuni.2015.02.017","article-title":"A broken Krebs cycle in macrophages","volume":"42","author":"O\u2019Neill","year":"2015","journal-title":"Immunity."},{"key":"10.1016\/j.bcp.2019.03.029_b1095","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b1100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b1105","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/art.20219","article-title":"Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis","volume":"50","author":"Iwahashi","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1110","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2353\/ajpath.2007.060657","article-title":"The Toll-like receptor adaptor proteins MyD88 and Mal\/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis","volume":"170","author":"Sacre","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2019.03.029_b1115","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/art.21278","article-title":"The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7\/8 results in synergistic cytokine production by dendritic cells","volume":"52","author":"Roelofs","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: all we need to know about danger","volume":"81","author":"Bianchi","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2019.03.029_b1125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.bor.0000127108.08398.34","article-title":"Pattern recognition receptors and their involvement in the pathogenesis of arthritis","volume":"16","author":"Seibl","year":"2004","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b1130","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm.1987","article-title":"Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease","volume":"15","author":"Midwood","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b1135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.30081","article-title":"Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fc\u03b3 receptor","volume":"63","author":"Sokolove","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1140","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1136\/annrheumdis-2012-202872","article-title":"The liver X receptor pathway is highly upregulated in rheumatoid arthritis synovial macrophages and potentiates TLR-driven cytokine release","volume":"72","author":"Asquith","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b1145","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13075-015-0736-9","article-title":"Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials","volume":"17","author":"Aletaha","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcp.2019.03.029_b1155","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI25422","article-title":"Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis","volume":"116","author":"Kuhn","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2019.03.029_b1160","doi-asserted-by":"crossref","first-page":"R458","DOI":"10.1186\/ar1697","article-title":"Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity","volume":"7","author":"Lundberg","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcp.2019.03.029_b1165","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","article-title":"Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin","volume":"122","author":"Harre","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2019.03.029_b1170","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/art.23284","article-title":"Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen","volume":"58","author":"Clavel","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1175","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/art.27386","article-title":"Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte\/macrophages and stimulate tumor necrosis factor alpha production","volume":"62","author":"Lu","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1180","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/annrheumdis-2014-206598","article-title":"Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis","volume":"75","author":"Rombouts","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b1185","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/art.1780360809","article-title":"Presence of estrogen-binding sites on macrophage-like synoviocytes and cd8+, cd29+, cd45ro+ t lymphocytes in normal and rheumatoid synovium","volume":"36","author":"Cutolo","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1190","first-page":"820","article-title":"Androgen and estrogen receptors are present in primary cultures of human synovial macrophages","volume":"81","author":"Cutolo","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"185","key":"10.1016\/j.bcp.2019.03.029_b1195","first-page":"1169","article-title":"17Beta-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor alpha signaling in macrophages in vivo","volume":"1950","author":"Calippe","year":"2010","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.bcp.2019.03.029_b1200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cellimm.2015.01.018","article-title":"Estrogen receptors regulate innate immune cells and signaling pathways","volume":"294","author":"Kovats","year":"2015","journal-title":"Cell. Immunol."},{"issue":"194","key":"10.1016\/j.bcp.2019.03.029_b1205","first-page":"2810","article-title":"Estradiol promotes M1-like macrophage activation through cadherin-11 to aggravate temporomandibular joint inflammation in rats","volume":"1950","author":"Kou","year":"2015","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.bcp.2019.03.029_b1210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0192-0561(88)90055-0","article-title":"Effect of estradiol on interleukin 1 synthesis by macrophages","volume":"10","author":"Hu","year":"1988","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.bcp.2019.03.029_b1215","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1210\/jc.2014-2751","article-title":"Alternative activation of human macrophages is rescued by estrogen treatment in vitro and impaired by menopausal status","volume":"100","author":"Toniolo","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2019.03.029_b1220","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/jbmr.5650050912","article-title":"Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women","volume":"5","author":"Ralston","year":"1990","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2019.03.029_b1225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.rdc.2004.10.001","article-title":"Estrogens and arthritis","volume":"31","author":"Cutolo","year":"2005","journal-title":"Rheum. Dis. Clin."},{"key":"10.1016\/j.bcp.2019.03.029_b1230","article-title":"Immunometabolism at the interface between macrophages and pathogens","volume":"1","author":"Russell","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b1235","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b1240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2249.1996.d01-820.x","article-title":"Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release","volume":"106","author":"Liot\u00e9","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b1245","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrrheum.2011.205","article-title":"Hypoxia\u2013a key regulator of angiogenesis and inflammation in rheumatoid arthritis","volume":"8","author":"Konisti","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b1250","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrrheum.2016.69","article-title":"Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis","volume":"12","author":"Fearon","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b1255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/path.1891","article-title":"Synovial fluid macrophages are capable of osteoclast formation and resorption","volume":"208","author":"Adamopoulos","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.bcp.2019.03.029_b1260","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1359-6101(02)00018-7","article-title":"Cytokines and anti-cytokine biologicals in autoimmunity: present and future","volume":"13","author":"Andreakos","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bcp.2019.03.029_b1265","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0958-1669(02)00355-5","article-title":"Monoclonal antibodies in immune and inflammatory diseases","volume":"13","author":"Andreakos","year":"2002","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bcp.2019.03.029_b1270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-62703-586-6_3","article-title":"Therapeutic human monoclonal antibodies in inflammatory diseases","volume":"1060","author":"Kotsovilis","year":"2014","journal-title":"Methods Mol. Biol. Clifton NJ."},{"key":"10.1016\/j.bcp.2019.03.029_b1275","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","article-title":"Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?","volume":"19","author":"Feldmann","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b1280","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.bcp.2019.03.029_b1285","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","article-title":"Tumor necrosis factor-\u03b1 signaling in macrophages","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.bcp.2019.03.029_b1290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/art.20764","article-title":"Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report","volume":"52","author":"Catrina","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1295","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L","article-title":"Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis","volume":"43","author":"Taylor","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1300","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/eji.1830211039","article-title":"Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha","volume":"21","author":"Haworth","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b1305","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b1310","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/acr.22803","article-title":"Examining changes in central and peripheral pain as mediates of fatigue improvement: results from the British society for rheumatology biologics register for rheumatoid arthritis","volume":"68","author":"Druce","year":"2016","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.bcp.2019.03.029_b1315","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10067-015-2861-x","article-title":"Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?","volume":"34","author":"Witte","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b1320","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","article-title":"Novel treatment strategies in rheumatoid arthritis","volume":"389","author":"Burmester","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2019.03.029_b1325","first-page":"2551","article-title":"Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from patients with rheumatoid arthritis","volume":"27","author":"Cutolo","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b1330","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/34.7.602","article-title":"Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells","volume":"34","author":"Seitz","year":"1995","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b1335","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/art.1780280702","article-title":"Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial","volume":"28","author":"Williams","year":"1985","journal-title":"Arthritis Rheum."},{"issue":"2017","key":"10.1016\/j.bcp.2019.03.029_b1340","first-page":"960","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b1345","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"OPTION Investigators, Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.bcp.2019.03.029_b1350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2016.03.028","article-title":"Modulation of human monocyte\/macrophage activity by tocilizumab, abatacept and etanercept: an in vitro study","volume":"780","author":"Obeng","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2019.03.029_b1355","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/14397595.2014.914016","article-title":"Effects of anti-IL-6 receptor antibody on human monocytes","volume":"25","author":"Tono","year":"2015","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b1360","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/art.1780390704","article-title":"Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group","volume":"39","author":"Campion","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1365","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/(SICI)1521-4141(199807)28:07<2143::AID-IMMU2143>3.0.CO;2-C","article-title":"Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice","volume":"28","author":"Matthys","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2019.03.029_b1370","first-page":"515","article-title":"ABT-874, a fully human monoclonal anti-IL-12\/IL-23 antibody for the potential treatment of autoimmune diseases","volume":"9","author":"Ding","year":"2008","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.bcp.2019.03.029_b1375","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.21249","article-title":"Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study","volume":"52","author":"Baslund","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1380","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1172\/JCI200112097","article-title":"Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis","volume":"108","author":"Plater-Zyberk","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2019.03.029_b1385","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"ERASURE Study Group, FIXTURE Study Group, Secukinumab in plaque psoriasis\u2013results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b1390","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.27334","article-title":"LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study","volume":"62","author":"Genovese","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1395","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","article-title":"Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis","volume":"366","author":"Papp","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b1400","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/ard.2010.146225","article-title":"Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-\u03b1, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study","volume":"70","author":"Burmester","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b1405","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/annrheumdis-2013-204816","article-title":"MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib\/IIa randomised, double-blind, placebo-controlled, dose-escalation trial","volume":"74","author":"Behrens","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b1410","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/annrheumdis-2016-210624","article-title":"EARTH EXPLORER 1 study investigators, a randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis","volume":"76","author":"Burmester","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.029_b1415","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1189\/jlb.68.1.144","article-title":"The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF","volume":"68","author":"Campbell","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2019.03.029_b1420","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/ar318","article-title":"Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease","volume":"3","author":"Cook","year":"2001","journal-title":"Arthritis Res."},{"key":"10.1016\/j.bcp.2019.03.029_b1425","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMoa035075","article-title":"Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig","volume":"349","author":"Kremer","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b1430","doi-asserted-by":"crossref","first-page":"235ra60","DOI":"10.1126\/scitranslmed.3007764","article-title":"T cell costimulation molecules CD80\/86 inhibit osteoclast differentiation by inducing the IDO\/tryptophan pathway","volume":"6","author":"Bozec","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b1435","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.7689748","article-title":"Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40","volume":"261","author":"Durie","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bcp.2019.03.029_b1440","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/art.24434","article-title":"Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis","volume":"60","author":"Andreakos","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1445","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/art.10856","article-title":"BG9588 Lupus Nephritis Trial Group, a short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis","volume":"48","author":"Boumpas","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1450","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1055\/s-0043-113690","article-title":"Die Behandlung des M. Meni\u00e8re mit Betahistin: Kritische Anmerkungen zur BEMED-Studie","volume":"21","author":"Ernst","year":"2017","journal-title":"Laryngo-Rhino-Otol."},{"key":"10.1016\/j.bcp.2019.03.029_b1455","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00228-017-2362-8","article-title":"Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases","volume":"74","author":"Albach","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2019.03.029_b1460","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa1507247","article-title":"Baricitinib in patients with refractory rheumatoid arthritis","volume":"374","author":"Genovese","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2019.03.029_b1465","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.semarthrit.2018.07.006","article-title":"A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population","volume":"48","author":"Kivitz","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1470","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1002\/art.11227","article-title":"Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653","volume":"48","author":"Nishikawa","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.03.029_b1475","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.clim.2007.03.543","article-title":"Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor","volume":"124","author":"Pine","year":"2007","journal-title":"Clin. Immunol. Orlando Fla."},{"key":"10.1016\/j.bcp.2019.03.029_b1480","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/BOR.0b013e3282fa13ee","article-title":"Is there a future for small molecule drugs in the treatment of rheumatic diseases?","volume":"20","author":"Stanczyk","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.029_b1485","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/art.24266","article-title":"Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis","volume":"60","author":"Cohen","year":"2009","journal-title":"Arthritis Rheum."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219301157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219301157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:08:08Z","timestamp":1762096088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219301157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":297,"alternative-id":["S0006295219301157"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.03.029","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The many facets of macrophages in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}